PVLA – palvella therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.